SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-09-140233
Filing Date
2009-06-29
Accepted
2009-06-29 12:32:34
Documents
2
Period of Report
2009-06-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 18062
2 FORM OF AMENDMENT TO PROMISSORY NOTES dex43.htm EX-4.3 9738
  Complete submission text file 0001193125-09-140233.txt   29862
Mailing Address 12255 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 12255 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 (858) 436-1000
Cardium Therapeutics, Inc. (Filer) CIK: 0000772320 (see all company filings)

IRS No.: 840635673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33635 | Film No.: 09915053
SIC: 2836 Biological Products, (No Diagnostic Substances)